Findings

What do systematic reviews say?

4,749 questions · 17,858 findings · 1,266 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,359 · 24.4%GRADE not reported 2,348 · 13.1%Very low 4,634 · 25.9%Low 4,000 · 22.4%Moderate 2,052 · 11.5%High 465 · 2.6%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Summary of findings table ‐ Rifampin/rifampicin vs placebo

Depression ‐ not measured · participants with cholestatic pruritus (CP)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Rifampin/rifampicin vs placebo

Risk for at least one adverse event per patient · participants with cholestatic pruritus (CP)

It is very uncertain whether summary of findings table ‐ Rifampin/rifampicin changes risk for at least one adverse event per patient compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
RR 0.29 [0.03, 2.51]
1 study · 39 participants
Very low

Flumecinol vs placebo

Pruritus: significant improvement · participants with cholestatic pruritus (CP)

It is very uncertain whether summary of findings table ‐ Flumecinol changes pruritus: significant improvement compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
RR 2.32 [0.54, 10.1]
2 studies · 69 participants
Very low

Flumecinol vs placebo

Pruritus · participants with cholestatic pruritus (CP)

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Low

Flumecinol vs placebo

Quality of life · participants with cholestatic pruritus (CP)

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Low

Flumecinol vs placebo

Patient satisfaction ‐ not measured · participants with cholestatic pruritus (CP)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gabapentin vs pregabalin

Pruritus · patients with chronic kidney disease (CKD) pruritus

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 100 participants
Low

Flumecinol vs placebo

Depression ‐ not measured · participants with cholestatic pruritus (CP)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Flumecinol vs placebo

Risk for at least one adverse event per participant ‐ not measured · participants with cholestatic pruritus (CP)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gabapentin vs pregabalin

Quality of life ‐ not reported · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gabapentin vs pregabalin

Patient satisfaction ‐ not reported · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gabapentin vs pregabalin

Depression ‐ not reported · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Frequency of wearing a seat belt assessed through self‐report · drivers or passengers travelling in passenger or commercial vehicles

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 986 participants
Low

Intervention not reported

Crash‐related injury rates · drivers or passengers travelling in passenger or commercial vehicles

The review found no eligible studies for this question.

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Crash‐related mortality rates · drivers or passengers travelling in passenger or commercial vehicles

The review found no eligible studies for this question.

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Frequency of wearing a seat belt · drivers or passengers travelling in passenger or commercial vehicles

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1407 participants
Low

Intervention not reported

Crash‐related injury rates · drivers or passengers travelling in passenger or commercial vehicles

The review found no eligible studies for this question.

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Crash‐related mortality rates · drivers or passengers travelling in passenger or commercial vehicles

The review found no eligible studies for this question.

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Frequency of wearing a seat belt · drivers or passengers travelling in passenger or commercial vehicles

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 118 participants
Low

Intervention not reported

Crash‐related injury rates · drivers or passengers travelling in passenger or commercial vehicles

The review found no eligible studies for this question.

1 finding from 1 review

Education, incentive, and engineering‐based interventions to promote the use of seat belts 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found